Cancer Biology

  1. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma

    1. Akshat Sarkari
    2. Sophie Korenfeld
    3. Karina Deniz
    4. Katherine Ladner
    5. Phillip Wong
    6. Sanyukta Padmanabhan
    7. Rachel I Vogel
    8. Laura A Sherer
    9. Naomi Courtemanche
    10. Clifford Steer
    11. Kerem Wainer-Katsir
    12. Emil Lou

    • Curated by eLife

      eLife assessment

      Overall, this is an interesting topic of study, and the conclusions could be of relevance more broadly. However, mechanistic support, limited TTF frequencies/timing, and visual support of the quantitative data would be critical in order to provide convincing and rigorous support for this interesting concept.

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity

  2. Construction of competing endogenous RNA interaction network as prognostic markers in metastatic melanoma

    1. Zan He
    2. Zijuan Xin
    3. Yongfei Peng
    4. Hua Zhao
    5. Xiangdong Fang

    Reviewed by PeerJ

    3 evaluationsAppears in 1 listLatest version Latest activity

  3. The Erlang distribution approximates the age distribution of incidence of childhood and young adulthood cancers

    1. Aleksey V. Belikov
    2. Alexey Vyatkin
    3. Sergey V. Leonov

    Reviewed by PeerJ

    4 evaluationsAppears in 1 listLatest version Latest activity

  4. Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness

    1. Dominik Koessinger
    2. David Novo
    3. Anna Koessinger
    4. America Campos
    5. Jasmine Peters
    6. Louise Dutton
    7. Peggy Paschke
    8. Désirée Zerbst
    9. Madeleine Moore
    10. Louise Mitchell
    11. Matthew Neilson
    12. Katrina Stevenson
    13. Anthony Chalmers
    14. Stephen Tait
    15. Joanna Birch
    16. Jim Norman

    Reviewed by preLights

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis

    1. Adrian J. Luna
    2. Jesse M. Young
    3. Rosa T. Sterk
    4. Virginie Bondu
    5. Fred A. Schultz
    6. Donna F. Kusewitt
    7. Huining Kang
    8. Michelle A. Ozbun

    Reviewed by preLights

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Flat clathrin lattices are linked to metastatic potential in colorectal cancer

    1. Charlotte Cresens
    2. Guillermo Solís-Fernández
    3. Astha Tiwari
    4. Rik Nuyts
    5. Johan Hofkens
    6. Rodrigo Barderas
    7. Susana Rocha

    Reviewed by preLights

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Functional synapses between small cell lung cancer and glutamatergic neurons

    1. Anna Schmitt
    2. Vignesh Sakthivelu
    3. Kristiano Ndoci
    4. Gulzar A Wani
    5. Marian Touet
    6. Isabel Pintelon
    7. Ilmars Kisis
    8. Olta Ibruli
    9. Julia Weber
    10. Roman Maresch
    11. Christina M Bebber
    12. Jonas Goergens
    13. Milica Jevtic
    14. Franka Odenthal
    15. Aleksandra Placzek
    16. Alexandru A Hennrich
    17. Karl-Klaus Conzelmann
    18. Maike Boecker
    19. Alena Heimsoeth
    20. Gülce S Gülcüler
    21. Ron D Jachimowicz
    22. Julie George
    23. Johannes Brägelmann
    24. Silvia von Karstedt
    25. Martin Peifer
    26. Thorsten Persigehl
    27. Holger Grüll
    28. Martin L Sos
    29. Jens Brüning
    30. Guido Reifenberger
    31. Matthias Fischer
    32. Dirk Adriaensen
    33. Reinhard Büttner
    34. Inge Brouns
    35. Roland Rad
    36. Roman K Thomas
    37. Matteo Bergami
    38. Elisa Motori
    39. Hans Christian Reinhardt
    40. Filippo Beleggia

    Reviewed by preLights

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The hexokinase “HKDC1” interaction with the mitochondria is essential for hepatocellular carcinoma progression

    1. Md. Wasim Khan
    2. Alexander R. Terry
    3. Medha Priyadarshini
    4. Grace Guzman
    5. Jose Cordoba-Chacon
    6. Issam Ben-Sahra
    7. Barton Wicksteed
    8. Brian T. Layden

    Reviewed by PREreview

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. Targeting a broad spectrum of KRAS -mutant cancers by hyperactivation-induced cell death

    1. Johanna Lilja
    2. Jasmin Kaivola
    3. James R.W. Conway
    4. Joni Vuorio
    5. Hanna Parkkola
    6. Pekka Roivas
    7. Taru Varila
    8. Guillaume Jacquemet
    9. Emilia Peuhu
    10. Emily Wang
    11. Ulla Pentikäinen
    12. Itziar Martinez D. Posada
    13. Hellyeh Hamidi
    14. Arafat K. Najumudeen
    15. Owen J. Sansom
    16. Igor L. Barsukov
    17. Daniel Abankwa
    18. Ilpo Vattulainen
    19. Marko Salmi
    20. Johanna Ivaska

    Reviewed by preLights

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer

    1. Paloma Cejas
    2. Yingtian Xie
    3. Alba Font-Tello
    4. Klothilda Lim
    5. Sudeepa Syamala
    6. Xintao Qiu
    7. Alok K. Tewari
    8. Neel Shah
    9. Holly M Nguyen
    10. Radhika A. Patel
    11. Lisha Brown
    12. Ilsa Coleman
    13. Wenzel M. Hackeng
    14. Lodewijk Brosens
    15. Koen M.A. Dreijerink
    16. Leigh Ellis
    17. Sarah Abou Alaiwi
    18. Ji-Heui Seo
    19. Mark Pomerantz
    20. Alessandra Dall’Agnese
    21. Jett Crowdis
    22. Eliezer M. Van Allen
    23. Joaquim Bellmunt
    24. Colm Morrisey
    25. Peter S. Nelson
    26. James DeCaprio
    27. Anna Farago
    28. Nicholas Dyson
    29. Benjamin Drapkin
    30. X. Shirley Liu
    31. Matthew Freedman
    32. Michael C. Haffner
    33. Eva Corey
    34. Myles Brown
    35. Henry W. Long

    Reviewed by PREreview

    2 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 39 of 43 Next